医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

NantHealth®, B. Braun Australia, GE Healthcare and iProcedures Join Forces to Bridge Connectivity Gap Between Patient Devices, Data and Medical Records at the Healthcare Information and Management Systems Society (HIMSS) Asia Pacific Con

2018年11月08日 AM04:24
このエントリーをはてなブックマークに追加


 

BRISBANE, Australia & CULVER CITY, Calif.

NantHealth (NASDAQ: NH), a leader in breakthrough cancer research and solutions to improve patient care and lower healthcare costs, today announced a collaboration with B. Braun Australia, GE Healthcare and iProcedures to demonstrate the exchange of data between devices and patient electronic medical records (EMRs).

The demonstration is taking place at the HIMSS Asia Pacific Conference, on November 5-8 in Brisbane, Australia, and illustrates how clinicians can spend less time on documentation and more time analyzing data in near real-time to improve patient outcomes. The companies’ connectivity solutions are featured as part of the HIMSS Interoperability Showcase.

NantHealth’s Connected Care solutions, including its expanded DeviceConX functionality, helps ensure critical information is readily available in EMRs. In a study of more than 500 registered nurses, 60 percent said medical errors could significantly decrease if hospital medical devices were coordinated and interoperable(1). Live demonstrations and use cases showcased how healthcare organizations can overcome this challenge using real-world examples:

  • GE Healthcare - Throughout a patient’s surgery, an anesthesiologist is able to leverage advanced clinical tools, note normal trends and steady vital sign flow from GE Healthcare’s fully digital Aisys CS2 anesthesia machine, gas module, and Carescape B850 patient monitor;
  • B. Braun Australia – The B. Braun Space Automated Infusion System is designed to support safe intravenous infusion therapy and drug administration throughout the hospital. The Infusomat Space (large volume) and the Perfusor Space (syringe) offers a wide range of delivery modes making them suitable for use in all care areas, including, but not limited to Anaesthetics. Both devices are WiFi capable with bi-directional communication. Infusion and drug delivery data can be sent to NantHealth’s DeviceConX;
  • NantHealth – DeviceConX can receive live streams of the data from all capable medical devices, and provide Unit of Measure (UoM) conversion and data normalization before sending the data to iProcedures iPro Anesthesia;
  • iProcedures – Using the iPro Anesthesia mobile device, the anesthesiologist can review and acknowledge before ultimately saving the information to the patient’s EMR.

“NantHealth is committed to helping healthcare systems overcome fragmentation in the clinical setting that can lead to time-consuming and error-prone data collection,” said Wesley Madden BSN, RN, NantHealth’s VP of Connectivity Sales. “This collaboration with B. Braun Australia, GE Healthcare and iProcedures is another example of our continued commitment to making sure healthcare providers have data readily available and free of transcription errors so they can better attend to patient needs. This demonstration illustrates successful interoperability, neutrality, and ease of implementation.”

For more information, visit NantHealth inside the HIMSS Interoperability Showcase™ at HIMSS AsiaPac ‘18 in booth #307 or at https://info.nanthealth.com/himssapac-2018.

(1) “Missed Connections: A Nurses Survey on Interoperability and Improved Patient Care,” 526 nurses surveyed January 7-16, 2015, commissioned by West Health Institute.

About NantHealth

NantHealth, Inc., a member of the NantWorks ecosystem of companies, is a next-generation, evidence-based, personalized healthcare company enabling improved patient outcomes and more effective treatment decisions for critical illnesses. NantHealth’s focused portfolio exemplifies its unique systems-based approach to personalized healthcare and integrates novel diagnostics with large-scale, biometric and phenotypic data to track patient outcomes and deliver precision medicine. For more information, please visit www.nanthealth.com.

About HIMSS

HIMSS is a global advisor and thought leading organization supporting the transformation of health through the application of information and technology. As a mission driven non-profit, HIMSS provides thought leadership, community building, public policy, professional/workforce development and engaging events to bring forward the voice of their members. HIMSS encompasses more than 70,000 global individual members, 630 corporate members, and over 450 non-profit organizations. Thousands of volunteers work through HIMSS to leverage the innovation of digital health to improve both the health of individuals and populations, as well as the quality, cost-effectiveness and access of healthcare. For more information, visit https://www.himss.org/.

© 2018 NantHealth, Inc.

View source version on businesswire.com: https://www.businesswire.com/news/home/20181107005799/en/

CONTACT

NANT
Jen Hodson
562-397-3639
Jen@nant.com

同じカテゴリーの記事 

  • Kolmar Korea Wins Case Against Italian Cosmetics Maker Intercos for Suncare Technology Theft
  • 大手CDMOのPCIファーマ・サービシズが初の包括ESG報告書を発表
  • Aurion Biotech Announces First Canadian Subject Dosed in Phase 1 / 2 Clinical Trial
  • 领先的合同开发和制造组织PCI Pharma Services发布首份综合ESG报告
  • EverEx Secures iF Design Award for “MORA,” a Leading Musculoskeletal Rehabilitation Solution